Otto Krieger

Revised International Prognostic Scoring System for Myelodysplastic Syndromes

Peter L. Greenberg, Heinz Tuechler, Julie Schanz et al. · Blood · 2012 · 3.1K citations · Full text

Medicine, Hematology, Internal Medicine +12

New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients

Detlef Haase, Ulrich Germing, Julie Schanz et al. · Blood · 2007 · 789 citations · Full text

Life Sciences, Genetics, Oncology +16

New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge

Julie Schanz, Heinz Tüchler, Françesc Solé et al. · Journal of Clinical Oncology · 2012 · 691 citations · Full text

Medicine, Hematology, Oncology +17

Coalesced Multicentric Analysis of 2,351 Patients With Myelodysplastic Syndromes Indicates an Underestimation of Poor-Risk Cytogenetics of Myelodysplastic Syndromes in the International Prognostic Scoring System

Julie Schanz, Christian Steidl, Christa Fonatsch et al. · Journal of Clinical Oncology · 2011 · 159 citations · Full text

Medicine, Hematology, Oncology +15

Detection of Circulating Mammary Carcinoma Cells in the Peripheral Blood of Breast Cancer Patients Via a Nested Reverse Transcriptase Polymerase Chain Reaction Assay for Mammaglobin mRNA

Otto Zach, H. Kasparu, Otto Krieger et al. · Journal of Clinical Oncology · 1999 · 155 citations

Medicine, Cancer Biology, Oncology +16